FDA clears Zoll Medical’s fully automatic AED Plus

The US Food and Drug Administration (FDA) has granted 510(k) approval to Zoll Medical's fully automatic version of ZOLL AED Plus.

Using the company’s proprietary feedback technology, Real CPR Help, the new fully automatic device provides high-quality manual CPR with real-time audible and visual feedback to help rescuers achieve the proper depth and rate of CPR chest compressions and improve survival from sudden cardiac arrests.

The new device, which includes the same features as the semiautomatic version of the AED Plus, has an additional benefit that a shock is delivered automatically, without requiring the rescuer push the Shock button, claims an Asahi Kasei Group company.

Research demonstrates that safety is not compromised when rescuers use a fully automatic rather than a semiautomatic AED.

Zoll Medical president Jonathan Rennert said, "Like the semiautomatic AED Plus, the fully automatic version guides rescuers through the complete Chain of Survival, helping all sudden cardiac arrest victims, not just those who need a shock."